Clarification from Russian expert organization regarding telmisartan BE studies [Regulatives / Guidelines]

posted by Beholder  – Russia, 2019-11-08 07:51 (527 d 15:00 ago) – Posting: # 20764
Views: 4,228

(edited by Beholder on 2019-11-08 11:27)

Hi to all!

An article which might serve as "guideline" for conducting telmisartan BE studies in Russia written by expert organization representative. Open access and abstract in English is available.

Main points represented in the article:
  1. 7 BE studies performed in Russia were assessed.
  2. Not only males should be enrolled but females as well (50/50).
  3. HPLC FLD is, in some cases, more sensitive than HPLC MS/MS (see study 3) ;-).

Best regards

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 11 (0 registered, 11 guests [including 3 identified bots]).
Forum time: Sunday 23:51 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz